372 related articles for article (PubMed ID: 9224205)
1. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.
Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q
Am J Respir Cell Mol Biol; 1997 Jul; 17(1):17-24. PubMed ID: 9224205
[TBL] [Abstract][Full Text] [Related]
2. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
[TBL] [Abstract][Full Text] [Related]
3. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
[TBL] [Abstract][Full Text] [Related]
4. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid.
Bradding P; Feather IH; Wilson S; Holgate ST; Howarth PH
Am J Respir Crit Care Med; 1995 Jun; 151(6):1900-6. PubMed ID: 7767538
[TBL] [Abstract][Full Text] [Related]
5. Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid.
Durham SR; Gould HJ; Thienes CP; Jacobson MR; Masuyama K; Rak S; Lowhagen O; Schotman E; Cameron L; Hamid QA
Eur J Immunol; 1997 Nov; 27(11):2899-906. PubMed ID: 9394816
[TBL] [Abstract][Full Text] [Related]
6. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
[TBL] [Abstract][Full Text] [Related]
7. Expression of IL-4, Cepsilon RNA, and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids.
Cameron LA; Durham SR; Jacobson MR; Masuyama K; Juliusson S; Gould HJ; Lowhagen O; Minshall EM; Hamid QA
J Allergy Clin Immunol; 1998 Mar; 101(3):330-6. PubMed ID: 9525448
[TBL] [Abstract][Full Text] [Related]
8. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids.
Masuyama K; Till SJ; Jacobson MR; Kamil A; Cameron L; Juliusson S; Lowhagen O; Kay AB; Hamid QA; Durham SR
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):610-7. PubMed ID: 9802369
[TBL] [Abstract][Full Text] [Related]
9. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
Ying S; Durham SR; Jacobson MR; Rak S; Masuyama K; Lowhagen O; Kay AB; Hamid QA
Immunology; 1994 Jun; 82(2):200-6. PubMed ID: 7927489
[TBL] [Abstract][Full Text] [Related]
10. Effect of topical fluticasone propionate on the mucosal allergic response induced by ragweed allergen and diesel exhaust particle challenge.
Diaz-Sanchez D; Tsien A; Fleming J; Saxon A
Clin Immunol; 1999 Mar; 90(3):313-22. PubMed ID: 10075860
[TBL] [Abstract][Full Text] [Related]
11. Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment.
Laberge S; Durham SR; Ghaffar O; Rak S; Center DM; Jacobson M; Hamid Q
J Allergy Clin Immunol; 1997 Oct; 100(4):569-74. PubMed ID: 9338554
[TBL] [Abstract][Full Text] [Related]
12. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
[TBL] [Abstract][Full Text] [Related]
13. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis.
Pullerits T; Lindén A; Malmhäll C; Lötvall J
Allergy; 2001 Sep; 56(9):871-7. PubMed ID: 11551252
[TBL] [Abstract][Full Text] [Related]
14. In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: effect of topical corticosteroids.
Ghaffar O; Christodoulopoulos P; Lamkhioued B; Wright E; Ihaku D; Nakamura Y; Frenkiel S; Hamid Q
Clin Exp Allergy; 2000 Jan; 30(1):86-93. PubMed ID: 10606935
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte/macrophage-colony stimulating factor in allergen-induced rhinitis: cellular localization, relation to tissue eosinophilia and influence of topical corticosteroid.
Nouri-Aria KT; Masuyama K; Jacobson MR; Rak S; Lowhagen O; Schotman E; Hamid Q; Durham S
Int Arch Allergy Immunol; 1998 Dec; 117(4):248-54. PubMed ID: 9876226
[TBL] [Abstract][Full Text] [Related]
16. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge.
Rak S; Jacobson MR; Sudderick RM; Masuyama K; Juliusson S; Kay AB; Hamid Q; Löwhagen O; Durham SR
Clin Exp Allergy; 1994 Oct; 24(10):930-9. PubMed ID: 7842362
[TBL] [Abstract][Full Text] [Related]
17. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation.
KleinJan A; McEuen AR; Dijkstra MD; Buckley MG; Walls AF; Fokkens WJ
J Allergy Clin Immunol; 2000 Oct; 106(4):677-86. PubMed ID: 11031338
[TBL] [Abstract][Full Text] [Related]
18. Effects of pollen and nasal glucocorticoid on FOXP3+, GATA-3+ and T-bet+ cells in allergic rhinitis.
Malmhäll C; Bossios A; Pullerits T; Lötvall J
Allergy; 2007 Sep; 62(9):1007-13. PubMed ID: 17686103
[TBL] [Abstract][Full Text] [Related]
19. Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid.
Sergejeva S; Malmhäll C; Lötvall J; Pullerits T
Clin Exp Allergy; 2005 Jan; 35(1):34-8. PubMed ID: 15649263
[TBL] [Abstract][Full Text] [Related]
20. Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation.
Baroody FM; Rouadi P; Driscoll PV; Bochner BS; Naclerio RM
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):899-906. PubMed ID: 9517609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
